RegeneRx Biopharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The analysis of RegeneRx Biopharmaceuticals Inc uses intelligence from across the web and also from available filings by RegeneRx Biopharmaceuticals Inc. The ESG rating covers 17 UN Sustainable Development Goals including: 'Quality Education', 'Decent Work & Economic Growth' and 'Life below Water'. The Sustainability score for RegeneRx Biopharmaceuticals Inc represents the company's transparency towards the United Nations Sustainable Development Goals.
RegeneRx Biopharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 4.0, social score of 5.3 and governance score of 8.0.
5.8
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
521 | Smruthi Organics Ltd | 5.9 | High |
521 | Vectura Group PLC | 5.9 | High |
541 | RegeneRx Biopharmaceuticals Inc | 5.8 | High |
541 | Cantargia AB | 5.8 | High |
541 | Amplia Therapeutics Ltd | 5.8 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does RegeneRx Biopharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does RegeneRx Biopharmaceuticals Inc disclose current and historical energy intensity?
Does RegeneRx Biopharmaceuticals Inc report the average age of the workforce?
Does RegeneRx Biopharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does RegeneRx Biopharmaceuticals Inc disclose its ethnicity pay gap?
Does RegeneRx Biopharmaceuticals Inc disclose cybersecurity risks?
Does RegeneRx Biopharmaceuticals Inc offer flexible work?
Does RegeneRx Biopharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does RegeneRx Biopharmaceuticals Inc disclose the number of employees in R&D functions?
Does RegeneRx Biopharmaceuticals Inc conduct supply chain audits?
Does RegeneRx Biopharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does RegeneRx Biopharmaceuticals Inc conduct 360 degree staff reviews?
Does RegeneRx Biopharmaceuticals Inc disclose the individual responsible for D&I?
Does RegeneRx Biopharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does RegeneRx Biopharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does RegeneRx Biopharmaceuticals Inc disclose water use targets?
Does RegeneRx Biopharmaceuticals Inc have careers partnerships with academic institutions?
Did RegeneRx Biopharmaceuticals Inc have a product recall in the last two years?
Does RegeneRx Biopharmaceuticals Inc disclose incidents of discrimination?
Does RegeneRx Biopharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has RegeneRx Biopharmaceuticals Inc issued a profit warning in the past 24 months?
Does RegeneRx Biopharmaceuticals Inc disclose parental leave metrics?
Does RegeneRx Biopharmaceuticals Inc disclose climate scenario or pathway analysis?
Does RegeneRx Biopharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does RegeneRx Biopharmaceuticals Inc disclose the pay ratio of women to men?
Does RegeneRx Biopharmaceuticals Inc support suppliers with sustainability related research and development?
Does RegeneRx Biopharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does RegeneRx Biopharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is RegeneRx Biopharmaceuticals Inc involved in embryonic stem cell research?
Does RegeneRx Biopharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does RegeneRx Biopharmaceuticals Inc disclose its waste policy?
Does RegeneRx Biopharmaceuticals Inc report according to TCFD requirements?
Does RegeneRx Biopharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does RegeneRx Biopharmaceuticals Inc disclose energy use targets?
Does RegeneRx Biopharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does RegeneRx Biopharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for RegeneRx Biopharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.